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Abstract
Maternal smoking during pregnancy has been found to influence newborn DNAmethylation in genes involved in fundamental
developmental processes. It is pertinent to understand the degree towhich the offspringmethylome is sensitive to the intensity
and duration of prenatal smoking. An investigation of the persistence of offspring methylation associated with maternal
smoking and the relative roles of the intrauterine and postnatal environment is alsowarranted. In the Avon Longitudinal Study
of Parents and Children, we investigated associations between prenatal exposure to maternal smoking and offspring DNA
methylation at multiple time points in approximately 800mother–offspring pairs. In cord blood, methylation at 15 CpG sites in
seven gene regions (AHRR, MYO1G, GFI1, CYP1A1, CNTNAP2, KLF13 and ATP9A) was associated with maternal smoking, and a
dose-dependent response was observed in relation to smoking duration and intensity. Longitudinal analysis of blood DNA
methylation in serial samples at birth, age 7 and 17 years demonstrated that someCpG sites showed reversibility ofmethylation
(GFI1, KLF13 and ATP9A), whereas others showed persistently perturbed patterns (AHRR, MYO1G, CYP1A1 and CNTNAP2). Of
those showing persistence,we explored the effect of postnatal smoke exposure and found that themajor contribution to altered
methylation was attributed to a critical window of in utero exposure. A comparison of paternal and maternal smoking and
offspring methylation showed consistently stronger maternal associations, providing further evidence for causal intrauterine
mechanisms. These findings emphasize the sensitivity of the methylome to maternal smoking during early development and
the long-term impact of such exposure.
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Introduction
Despite the known health risks to both mothers and newborns,
maternal smoking during pregnancy remains a significant public
health problem in high-income countries and recent reports sug-
gest that∼12%ofmothers in England are still smoking at the time
of delivery (1). Exposure of the fetus to maternal smoking in utero
has been associated with adverse perinatal outcomes, including
low birth weight (2–4), elevated blood pressure (5,6), obesity (7,8)
and behavioural difficulties in childhood (9,10). It has been pro-
posed that epigenetic modifications such as DNA methylation
may mediate the adverse developmental consequences asso-
ciated with smoking during pregnancy (11).
Cigarette smoke is an established environmental associate of
DNA methylation (12–17) and maternal smoking in pregnancy
has recently been found to be associated with levels of DNA
methylation in large-scale epigenome wide association studies
(EWAS) of cord blood (18) and infant whole blood shortly after
delivery (19). Of particular importance is the observation that
maternal smoking during pregnancy is associated with changes
inmethylation in genes involved in fundamental developmental
processes (18,19).
The associations found between maternal cotinine levels, an
objective biomarker of smoking and DNA methylation in new-
borns imply a dose-dependent effect of maternal smoking in
pregnancy (18). The sensitivity of the offspring methylome to
the intensity (19) and duration (20) of smoking during pregnancy
has been further explored. Of potential relevance is the impact of
maternal smoking in early pregnancy, when women may not be
aware that they are pregnant. During the early phases of embryo-
genesis, the products of tobacco smoke may induce soma-wide
modification of DNA methylation in the exposed offspring,
whichmay be then bemaintained into postnatal life (21,22). Con-
versely, a recent study of DNAmethylation in newborns found no
difference in methylation between the offspring of mothers who
never smoked and those who smoked early in pregnancy (23). It
has also been shown that the effect of in utero exposure on new-
born methylation is stronger when the mother smoked past 18
weeks than when she quit earlier in pregnancy (20). These find-
ings warrant further investigation in an independent study.
Associations between own smoking and methylation at later
time points have been found (15,24), with one study of former
smokers showing that methylation in a key gene region asso-
ciated with smoking (AHRR) approaches the levels of never smo-
kers within the first few years of quitting, but never completely
returns to normal levels (15). Two recent studies have also inves-
tigated prospective associations between maternal smoking in
pregnancy and peripheral blood methylation in offspring when
they were children (25) and adolescents (26). A high degree of
similarity was found with smoking-associated DNAmethylation
in newborns (18), implying a lasting effect ofmaternal smoking in
pregnancy on offspring DNA methylation profiles. However, a
more comprehensive longitudinal assessment of intrauterine
exposure and methylation levels in the same offspring assessed
at multiple time points is required.
The relative roles of the intrauterine and postnatal environ-
ment in the persistence of DNA methylation changes associated
with maternal smoking are yet to be determined. Previous stud-
ies have shown that associations between prenatal exposure to
maternal cigarette smoking and offspring methylation during
adolescence are not attenuated with adjustment for postnatal
smoking of the parents or the offspring themselves (25,26).
However, the method of adjusting for a potential mediator in
standard regression models to estimate the direct effect of an
exposure may produce spurious conclusions (27,28). Alternative
methods are therefore required to test the hypothesis thatmater-
nal smoking in pregnancy is the ‘critical period’ for influencing
offspring methylation profiles in childhood and adolescence
(29). Finally, given that some of the signals found for prenatal
smoke exposure have also been identified in a study of personal
smoking of adolescents (30), any apparent persistent effect of
maternal smoking on offspring methylation profile at later ages
may be explained by smoking of the adolescents themselves.
Epigenetic markers, in contrast to germ-line genetic variation
(31), are phenotypic and are therefore subject to the same poten-
tial problems of confounding which afflict observational epi-
demiology (32,33). Hence, there is a need to apply a range of
tools for strengthening causal inference in epigenetic epidemi-
ology (34,35). One suchmethod for inferring a causal intrauterine
effect involves the use of paternal exposures as negative controls
formaternal exposures thought to have an intrauterine influence
on offspring outcomes (34,36–40). Paternal smoking may show
associations with offspring methylation similar to those of
maternal smoking in pregnancy if the associations are con-
founded either by shared familial factors or by parental geno-
types. However, if there is an intrauterine influence of maternal
smoking, then only maternal exposure would be expected to
show an independent association with the outcome.
We use the Accessible Resource for Integrated Epigenomic
Studies (ARIES), a large collection of genome-wide DNAmethyla-
tion data from multiple time points in mothers and offspring
from the Avon Longitudinal Study of Parents and Children
(ALSPAC) (41,42) to (1) replicate findings of a recently reported
EWAS for maternal cotinine (18) by investigating associations
between self-reported maternal smoking in pregnancy and off-
spring cord blood methylation using the Illumina Infinium®
HumanMethylation450 (HM450) BeadChip; (2) explore the dose-
dependent effect of maternal smoking by investigating associa-
tions between the duration and intensity of maternal smoking
and offspring cord blood methylation at key CpG sites; (3) exam-
ine the persistence of DNAmethylation changes at key CpG sites
by investigating longitudinal associations at multiple time
points, from birth to 17 years; (4) investigate the relative roles of
the intrauterine and postnatal environment in the persistence of
DNA methylation modifications; (5) assess potential causality in
associations between maternal smoking during pregnancy and
offspring DNA methylation at multiple time points, using pater-
nal smoking as a negative control.
Results
Baseline characteristics
Compared with offspring in the core ALSPAC sample who are not
part of the ARIES project, those in ARIES were more likely to be
singletons, had a higher birth weight on average, had a longer
gestation and had mothers who were: older at time of delivery,
more highly educated, from a higher social class, more likely to
drink alcohol in pregnancy and less likely to smoke in pregnancy
(Table 1).
Of the 1018 mother–offspring pairs in the ARIES project, 916
offspring had cord blood methylation data, which successfully
passed quality control (QC). Seven hundred and ninety had data
on both sustained smoking in pregnancy and cord blood DNA
methylation. Of these, 699 were classified as non-smokers and
91 were classified as sustained smokers during pregnancy. Com-
pared with the non-smokers, sustained smokers were more likely
to be younger at time of delivery, less well educated, from a lower
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social class, less likely to drink in pregnancy and more likely to
have partners who also smoked in pregnancy (Table 2).
EWAS for maternal smoking in pregnancy and
cord blood methylation
In an unadjusted analysis of the associations between maternal
smoking in pregnancy and cord blood epigenome-wide methyla-
tion levels, 15 CpG sites fell below the Bonferroni threshold for
significance of 1.07 × 10−7 and 28 CpG sites fell below the false dis-
covery rate (FDR) cut-off of 0.05 (Fig. 1 and Table 3). Of the CpG sites
falling below the Bonferroni threshold, thesewere located in seven
gene regions andmost have been previously identified in EWAS for
maternal smoking, with the top hit in AHRR (cg05575921) being
consistently replicated (18,19). The effects of smoking onmethyla-
tion levels were directionally consistent with previous studies
(23,24) for all of these sites, with hypomethylation of sites at
AHRR, GFI1 and CNTNAP2 and hypermethylation of MYO1G and
CYP1A1 in the offspring of smokers compared with non-smokers.
Of the CpG sites which fell below the FDR but not the Bonferroni
threshold, five of these CpG sites were also located in the AHRR,
GFI1, CYP1A1 and MYO1G gene regions. Other gene regions har-
bouring CpG sites associated withmaternal smoking at Bonferroni
significance were KLF13 and ATP9A and at FDR significance were
GNG12, ENSG00000225718, CTNNA2, NOTCH1, ALS2CL, CHI3L1,
ZNF710 and SPATS2. Sites at ATP9A, GNG12 and ENSG00000225718
have previously identified in other EWAS for maternal smoking
(18,19), but the other sites appear to be novel.
The sample size was reduced to 744 participants once all cov-
ariateswere included in the adjustedmodel. Resultswere slightly
attenuated in the model adjusting for a number of potential con-
founding factors and 12 probes no longer reached the FDR cut-off
for epigenome-wide significance (Table 3). This reduction in the
number of CpG sites reaching epigenome-wide significance
with adjustment for confounders is likely due to a loss of power
with a reduced sample size, because themagnitude and direction
of methylation difference at all the sites were similar.
Wenext investigatedwhetheranyof theCpGsites that reached
epigenome-wide significance in ourmain analysis were identified
as being either single nucleotide polymorphism (SNP)-con-
founded or cross-hybridizing based on a comprehensive assess-
ment reported by Naeem et al. (43). Five CpG sites identified in
the original analysis were flagged by this study as sites to exclude
as SNPs are known to overlap the probe region (Table 3).
Evidence for a difference in four of the six estimated cell
proportions was found between non-smokers and sustained
smokers (Supplementary Material, Table S1). To establish the
effect of correcting for cell type, we added the predicted cell-
type components as covariates in the main model. Results were
largely unalteredwith this adjustment (Supplementary Material,
Table S2).
We also explored whether there were any sex-specific asso-
ciations by stratifying the analysis based on sex of the offspring
(Supplementary Material, Table S3). This analysis involved 388
boys and 402 girls. In boys, three CpG sites reached the FDR
threshold for epigenome-wide significance, located in AHRR,
MYO1G and CYP1A1. In girls, three CpG sites reached the FDR
threshold for epigenome-wide significance, located in AHRR,
MYO1G and GFI1. These same sites were among the top hits in
the combined analysis. There was some evidence for an inter-
action by sex at AHRR (cg05575921), where the methylation
change associated with sustained smoking was larger in girls
than in boys and at CYP1A1 (cg05549655) where the methylation
change was larger in boys than in girls. However, there was lim-
ited evidence for a difference in effect size between boys and girls
at the other CpG sites in these same gene regions, providing no
strong evidence for sex-specific associations.
Given that most of the CpG sites falling below the Bonferroni
threshold were located within common genomic regions, we used
coMET (44), a web-based plotting tool, to visualize the genomic
regions of interest from our EWAS (Supplementary Material, Figs
S1–S7). There was some evidence for localized clustering around
the top CpG site (that with the smallest P-value in the EWAS) in
AHRR,MYO1G, GFI1 and CYP1A1, although therewas little evidence
for strong co-methylation within the gene regions indicating
independence in methylation levels at each CpG site. However,
we decided to only take forward the CpG site with the smaller
P-value in each gene region to focus our downstream analyses.
Dose-dependence of cord blood methylation
on maternal smoking
To investigate dose-dependent effects ofmaternal smoking on cord
blood methylation in the offspring, we ran an exploratory analysis
for the top CpG sites in each of the seven gene regions identified
in the main combined analysis: AHRR (cg05575921), MYO1G
(cg22132788), GFI1 (cg09935388), CYP1A1 (cg05549655), CNTNAP2
(cg25949550), KLF13 (cg26146569) and ATP9A (cg07339236). We
found that cord blood methylation differences between the off-
spring of mothers who smoked in pregnancy compared with that
of non-smokers were more extreme with both increased duration
(number of trimesters; Fig. 2) and intensity (average number of ci-
garettes per day) of smoking in pregnancy (Fig. 3), though this
trend was more pronounced at some sites than others, e.g. AHRR
Table 1. Baseline characteristics for individuals in ARIES compared with those in the ALSPAC core cohort who were not part of ARIES
Individuals in ARIES (N = 1018)a Individuals not in ARIES (N = 14 062)a P-value for difference
Sex (% males) 48.8 51.7 0.056
Multiple births (% singletons) 99.6 97.1 <0.001
Birth weight (g) 3487.4 (488.1) 3377.1 (577.9) <0.001
Gestational age (weeks) 39.6 (1.5) 39.3 (2.1) <0.001
Maternal age (years) 30.0 (4.4) 28.3 (5.0) <0.001
Maternal parity (% parous) 53.6 55.5 0.26
Maternal education (% university degree) 20.5 12.2 <0.001
Household social class (% non-manual) 88 79.8 <0.001
Maternal BMI (kg/m2) 22.8 (3.7) 22.9 (3.8) 0.18
Alcohol during pregnancy? (% yes) 66.7 63.1 0.024
Mother smoked during pregnancy? (% yes) 14.3 30.2 <0.001
aN varies according to completeness of data on baseline characteristics.
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(cg05575921) (P = 2.7 × 10−42) versus ATP9A (cg07339236) (P = 9.9 ×
10−3) for the duration of smoking in pregnancy.
Longitudinal analysis of maternal smoking in
pregnancy and offspring methylation
Longitudinal analyseswere performed to investigatewhether the
effect of smoking on offspringmethylation at birth was transient
or persisted into later life. Methylation data were available for
offspring in ARIES at age 7 [mean age when blood samples were
taken 7.5 (SD 0.1)] and at age 17 [mean age 17.1 (SD 1.0)].We inves-
tigated changes in methylation levels for the CpG sites that
were found to be associated with maternal smoking in cord
blood using multilevel modelling (Fig. 4 and Supplementary
Material, Table S4). For the seven CpG sites, there were changes
in methylation found during childhood, while the magnitude
of change was quite small during adolescence. At CYP1A1
(cg05549655) and CNTNAP2 (cg25949550), while there was some
evidence for change in methylation among the offspring of the
smokers and non-smokers over time, the difference in methyla-
tion between groups persisted. Evidence for differing rates of
change in methylation level between the offspring of smokers
and non-smokers was found at AHRR (cg05575921), MYO1G
(cg22132788), GFI1 (cg09935388) and KLF13 (cg26146569) between
birth and age 7 (P-value for difference in methylation change
0.01–1 × 10−16).
AtMYO1G (cg22132788), methylation level for the offspring of
smokers deviated more from the level of the offspring of non-
smokers over time, whereas at GFI1 (cg09935388) and KLF13
(cg26146569) there was some recovery of methylation towards
the level of those not exposed to prenatal maternal smoke. At
AHRR (cg05575921) during childhood, methylation increased
at a faster rate in the offspring of smokers with evidence for a
‘catchup’ in methylation among the offspring of smokers
[a 2.04% (95% CI 1.72, 2.36%) average yearly increase in methyla-
tion for the offspring of sustained smokers compared with a
1.28% (95% CI 0.97, 1.59%) increase in methylation for the off-
spring of non-smokers, between birth and age 7]. However, dur-
ing adolescence, levels of AHRR (cg05575921) methylation
decreased among both the smoker and non-smoker offspring,
with methylation in the smoker offspring decreasing at a faster
rate [a 0.33% (95% CI 0.26, 0.40%) average yearly decrease in
methylation for the offspring of sustained smokers compared
with a 0.17% (95% CI 0.12, 0.22%) decrease in methylation for
the offspring of non-smokers, between age 7 and 17], leading
again to a difference in methylation levels. A similar trend was
found for ATP9A (cg07339236), although this was not as robust.
For the CpG sites which showed a persistent difference in
methylation between the offspring of smokers and non-smokers
[MYO1G (cg22132788), CYP1A1 (cg05549655) and CNTNAP2
(cg25949550); Fig. 4], we sought to determine whether the asso-
ciations with maternal smoking were explained by a direct ‘crit-
ical period’ effect of smoking in pregnancy or via an indirect
pathway involving postnatal smoke exposure. Identifying these
underlying mechanisms of association is hampered by the high
correlation (0.87) between sustained smoking in pregnancy and
maternal smoking at 8 weeks postnatally. To disentangle the
effect of smoking in pregnancy on offspring methylation versus
smoking postnatally, we implemented a structured approach to
model the effects of the binary maternal smoking exposure at
three time points (in pregnancy and postnatally at 8 weeks and
61 months) on offspring methylation at age 7 (Table 4). The hy-
pothesis for an in utero critical period is supported by data at all
three CpG sites, with this model not being substantially different
from the saturated model (P ≥ 0.06). However, a model for effect
modification of the intrauterine exposure was also supported
by the data (P≥ 0.06) and for CYP1A1 and CNTNAP2 a critical per-
iod at 8 weeks postnatally could not be ruled out (P≥ 0.18). As the
in utero critical periodmodel is nested within the effect modifica-
tion model, we further performed a direct ANOVA test to investi-
gate whether effect modification provided a better fit of the data
than the in utero critical period model. This was found to be the
case for CYP1A1 (P = 0.009), but not for MYO1G or CNTNAP2 (P ≥
0.22), where the in utero critical period was found to be the best
model (Table 4).
For the CpG sites which showed evidence of methylation
difference between the offspring of smokers and non-smokers
at age 17 [AHRR (cg05575921), MYO1G (cg22132788), CYP1A1
Table 2. Differences in potential confounding factors between
individuals in ARIES whose mothers did not smoke in pregnancy
compared with sustained smokers
Non-smoker
(N = 699)a
Sustained
(N = 91)a
P-value for
difference
Sex
Male 49.4 47.3 0.71
Female 50.6 52.8
Maternal age (years) 30.5 (4.1) 27.9 (5.4) <0.001
Maternal age (categories)
<25 7.6 30.8 <0.001
25–30 39.2 37.4
>30 53.2 31.9
Parity
0 45.5 51.1 0.53
1 37.7 32.2
2 13.2 11.1
3+ 3.6 5.6
Maternal education
CSE/vocational 13.9 33.0 <0.001
O-level 32.7 40.9
A-level 30.4 18.2
Degree 23.1 8.0
Social class
I 22.9 4.9 <0.001
II 44.0 39.0
III (NM) 24.4 20.7
III (M) 5.3 22.0
IV or V 3.5 13.4
Maternal BMI 22.8 (3.7) 23.0 (3.6) 0.63
Maternal BMI (categories)
<18.5 3.3 3.5 0.59
18.5–25 79.1 76.5
25–30 13.1 14.1
30+ 4.6 5.9
Maternal weight 61.6 (10.4) 61.5 (10.5) 0.95
Alcohol
Non-drinker 34.2 40.9 0.040
Drank before
18 weeks of
gestation
15.6 5.7
Still drinking at
18 weeks of
gestation
50.2 53.4
Paternal smoking
Non-smoker 78.6 20.9 <0.001
Smoker 21.4 79.1
aN varies according to completeness of data on baseline characteristics.
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(cg05549655) and CNTNAP2 (cg25949550); Fig. 4], we followed up
the association between methylation at these sites and own
smoking among the adolescents (Supplementary Material,
Table S4). The correlation between sustained smoking in preg-
nancy and own smoking (of the adolescent) was found to be
0.16. For the majority of CpG sites for which the association with
smoking in pregnancywas evident at age 17, therewas directional
consistency of the association between own smoking andmethy-
lation at this time point. However, the magnitude of the associ-
ation with own smoking was smaller than for the sustained
maternal prenatal smoking analysis at all CpG sites, with the ex-
ception of AHRR (cg05575921), where the effect size for sustained
smoking in pregnancy was −3.6% (95% CI −4.6, −2.6%) compared
with −3.4% (95% CI −4.4, 2.4%) for the own smoking analysis, sug-
gesting that not all of the association between maternal smoking
inpregnancyandage 17methylationcanbeexplained through the
mediating role of the adolescent’s own smoking.
We next investigated the associations between sustained
smoking in pregnancy and methylation at age 17, excluding
those offspring who reported smoking themselves (Supplemen-
tary Material, Table S5). The magnitude and direction of associ-
ation of the CpG sites were comparable to those in the full
analysis, providing more evidence that own smoking is not fully
mediating the observed association between maternal smoking
in pregnancy and offspring methylation at age 17. In addition,
this was with the notable exception of CpG sites at AHRR, where
the effect size was halved [from −3.6% (95% CI −4.6, −2.6%) to
−1.8% (95%CI 0.0,−3.6%)]whenadolescentswho reported smoking
were excluded from the analysis. This provides some indication
that personal smoking by adolescents and its correlation withma-
ternal smoking could be driving the apparent persistent methyla-
tion difference in this gene region at age 17.
Assessing causality of intrauterine associations
using paternal smoking as a negative control
Finally, parental comparisons of associations between smoking
during pregnancy and methylation levels at the top CpG sites
showed consistently larger effect estimates for prenatalmaternal
smoking than for paternal smoking at all three time points
(Fig. 5). In addition, adjusting for paternal smoking in maternal
associations made little difference to affect estimates while ad-
justing for maternal smoking attenuated all paternal associa-
tions. For example, in the analysis of methylation in cord blood,
any smoking bymothers during pregnancywas associatedwith a
6.1% (95% CI −7.1, −5.1%) reduction in cord blood methylation at
cg05575921 (AHRR), which was not substantially attenuated
with adjustment for partner’s smoking (−5.6%; 95% CI −6.7,
−4.5%). Smoking by partners during pregnancy was associated
with a 2.1 (−2.8, −1.3%) reduction in cord blood methylation at
cg05575921 (AHRR), which was fully attenuated with adjustment
for maternal smoking (−0.01%; 95% CI −0.01, 0.00%).
Discussion
In a large longitudinal birth cohort with genome-wide methyla-
tion measured at three different time points in the offspring,
we first identified 15 CpG sites that were differentially methy-
lated in cord blood at birth. These sites are located in seven
gene regions, six of which have been previously identified in
other EWAS for exposure to maternal smoking in utero (18,19).
The top hit in this analysis was located within the AHRR [aryl
hydrocarbon receptor (AHR) repressor] gene. CpG sites located
in this gene region have previously been shown to be differential-
lymethylated in smokers in several studies (13–18,30). In particu-
lar, the top hit in this analysis (cg05575921, P = 1.41 × 10−30) was
identified in previous studies including an epigenome-wide as-
sociation study for maternal smoking and both cord and neo-
natal blood DNA methylation (18).
At this site, an 8.1% (95% CI 6.9, 9.3%) reduction in cord blood
methylation with sustained prenatal smoking exposure was
identified, which is in line with the median methylation differ-
ence of medium and high cotinine versus no exposure in a previ-
ous EWAS (18), which was 5.4 and 9.9%, respectively. These
associations were largely robust to adjustment for a number
of genetic, environmental and cell-type specific confounding
factors, supporting a causal effect of maternal smoking during
pregnancy on offspring methylation at birth. However, for two
Figure 1.Manhattan andQQplot for epigenome-wide association study of sustained smoking in pregnancyon cord bloodDNAmethylation. *Results are from the analysis
adjusted for batch only (N = 790).
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Table 3. Differential methylation in cord blood DNA for the offspring of mothers with sustained smoking in pregnancy compared with non-smokers
CpG site Chromosome Gene region Positionc Unadjusted model (N = 790†)a Adjusted model (N = 744‡)b
Effect size Standard error P-value FDR Effect size Standard error P-value FDR
cg05575921 5 AHRR 373 378 −0.081 0.006 1.41 × 10−30 6.59 × 10−25 −0.075 0.007 7.64 × 10−18 3.56 × 10−12
cg22132788 7 MYO1G 45 002 486 0.062 0.010 1.49 × 10−17 3.47 × 10−12 0.054 0.012 1.72 × 10−10 3.03 × 10−5
cg12803068 7 MYO1G 45 002 919 0.152 0.021 1.22 × 10−16 1.90 × 10−11 0.126 0.025 4.47 × 10−9 3.47 × 10−4
cg09935388 1 GFI1 92 947 588 −0.167 0.023 1.14 × 10−13 1.19 × 10−8 −0.174 0.028 1.95 × 10−10 3.03 × 10−5
cg14179389 1 GFI1 92 947 961 −0.078 0.012 1.28 × 10−13 1.19 × 10−8 −0.070 0.015 2.49 × 10−8 1.45 × 10−3
cg18146737 1 GFI1 92 946 700 −0.144 0.019 2.67 × 10−13 2.07 × 10−8 −0.141 0.024 2.10 × 10−9 1.96 × 10−4
cg05549655 15 CYP1A1 75 019 143 0.015 0.002 1.05 × 10−12 6.99 × 10−8 0.016 0.002 4.73 × 10−10 5.51 × 10−5
cg06338710 1 GFI1 92 946 187 −0.214 0.032 1.32 × 10−10 7.69 × 10−6 −0.200 0.039 5.93 × 10−7 0.02
cg12876356 1 GFI1 92 946 825 −0.179 0.029 1.60 × 10−9 8.27 × 10−5 −0.206 0.035 1.36 × 10−8 9.09 × 10−4
cg25949550 7 CNTNAP2 145 814 306 −0.006 0.001 3.06 × 10−9 1.43 × 10−4 −0.006 0.001 8.08 × 10−6 0.09
cg11902777 5 AHRR 3 68 843 −0.005 0.001 1.59 × 10−8 6.74 × 10−4 −0.004 0.001 5.62 × 10−5 0.17
cg12101586 15 CYP1A1 75 019 203 0.060 0.010 2.18 × 10−8 8.49 × 10−4 0.070 0.013 5.71 × 10−8 2.96 × 10−3
cg18316974
d
1 GFI1 92 947 035 −0.083 0.019 4.05 × 10−8 1.45 × 10−3 −0.086 0.023 4.96 × 10−6 0.08
cg26146569 15 KLF13 31 637 592 −0.072 0.013 4.61 × 10−8 1.54 × 10−3 −0.083 0.016 2.97 × 10−7 0.01
cg07339236
d
20 ATP9A 50 312 490 −0.016 0.004 8.71 × 10−8 2.71 × 10−3 −0.014 0.006 3.60 × 10−4 0.24
cg09662411 1 GFI1 92 946 132 −0.127 0.024 1.26 × 10−7 3.66 × 10−3 −0.147 0.029 6.60 × 10−7 0.02
cg18092474 15 CYP1A1 75 019 302 0.077 0.016 2.17 × 10−7 5.94 × 10−3 0.057 0.019 5.12 × 10−4 0.24
cg04180046 7 MYO1G 45 002 736 0.050 0.011 2.29 × 10−7 5.94 × 10−3 0.043 0.012 4.23 × 10−5 0.16
cg25189904 1 GNG12 68 299 493 −0.055 0.011 4.32 × 10−7 0.01 −0.052 0.013 1.20 × 10−4 0.20
cg04598670 7 ENSG00000225718 68 697 651 −0.074 0.015 4.80 × 10−7 0.01 −0.074 0.018 4.35 × 10−5 0.16
cg27629977 2 CTNNA2 80 531 633 0.009 0.002 5.82 × 10−7 0.01 0.012 0.003 4.07 × 10−7 0.01
cg10835306 9 NOTCH1 139 396 760 −0.079 0.016 1.04 × 10−6 0.02 −0.061 0.019 2.34 × 10−3 0.30
cg00483459 3 ALS2CL 46 735 782 −0.049 0.010 1.32 × 10−6 0.03 −0.056 0.011 2.19 × 10−6 0.05
cg22549041
d
15 CYP1A1 75 019 251 0.069 0.014 1.42 × 10−6 0.03 0.089 0.017 2.60 × 10−7 0.01
cg22937882
d
5 AHRR 4 05 774 0.036 0.008 1.98 × 10−6 0.04 0.036 0.011 3.13 × 10−4 0.24
cg11196333 1 CHI3L1 203 154 370 −0.060 0.013 2.58 × 10−6 0.05 −0.066 0.015 1.06 × 10−5 0.11
cg00624799
d
15 ZNF710 90 605 618 −0.029 0.006 2.79 × 10−6 0.05 −0.037 0.007 4.19 × 10−7 0.01
cg00560284 12 SPATS2 49 783 222 −0.016 0.003 2.84 × 10−6 0.05 −0.013 0.004 1.79 × 10−3 0.29
Effect size = difference in methylation level (beta) between offspring of sustained smokers and non-smokers.
aAdjusted for batch only: †N = 91 sustained smokers; N = 699 non-smokers (defined as those who did not smoke pre-pregnancy or in pregnancy).
bAdjusted formaternal age,maternal education, household social class, paternal smoking,maternal alcohol in pregnancyand batch: ‡N = 76 sustained smokers;N = 668non-smokers (defined as thosewhodid not smoke pre-pregnancy
or in pregnancy).
cChromosomal position based on NCBI human reference genome assembly Build 37.3.
dNaeem flagged CpG site (43).
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Figure 2. Methylation level (beta) at key CpG sites associated with sustained smoking in pregnancy by the duration of smoking (number of trimesters).
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Figure 3. Methylation level (beta) at key CpG sites associated with sustained smoking in pregnancy by the intensity of smoking (number of cigarettes per day).
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of the CpG sites followed up in downstream analysis, CNTNAP2
(cg25949550) and ATP9A (cg07339236), the FDR P-values were
0.09 and 0.24, respectively, in the adjusted model, but effect esti-
mates were largely unchanged between the adjusted and un-
adjusted model. In addition, ATP9A (cg07339236) was flagged up
in Table 3 as a low-quality probe based on a comprehensive as-
sessment reported by Naeem et al. (43).
A regional analysis of EWAS hits provided some evidence for
localized clustering around the top CpG site (that with the smallest
P-value in the EWAS) in AHRR,MYO1G, GFI1 and CYP1A1, although
there was little evidence for strong co-methylation within the
gene regions indicating independence of methylation levels at
eachCpGsite, supportingouruseof single site analysis in theEWAS.
We assessed the biological gradient of smoke exposure
in pregnancy and identified a dose-dependent response of
methylationwith both increased intensity and duration of smok-
ing. In this analysis, we found thatmethylation in the offspring of
motherswho smoked only in one trimester, namely the first, was
largely comparable to that of unexposed offspring. These find-
ings are in line with previous studies, which showed no differ-
ence in mean methylation at AHRR between mothers who
never smoked and those who smoked early in their pregnancy
(20,23), suggesting that sustained exposure to maternal smoking
in utero is required to induce changes in methylation which are
detectable in cord blood. In contrast to the view that early preg-
nancy represents a critical window for environmentally induced
epigenetic change, epigenetic reprogramming appears to occur
throughout prenatal development and postnatally (45) and
these findings imply a cumulative effect of smoke exposure
throughout pregnancy on offspring methylation at birth.
Figure 4. Longitudinal trajectories of methylation at key CpG sites in the offspring of non-smokers and sustained smokers during pregnancy from birth to age 17.
Table 4. An exploration of critical period and other lifecourse effects that may underlie the persistence of associations between maternal smoke
exposure in pregnancy and offspring methylation at age 7
Lifecourse hypothesis MYO1G (cg22132788) CYP1A1 (cg05549655) CNTNAP2 (cg25949550)
F-statistic P-value F-statistic P-value F-statistic P-value
Critical period in pregnancy 0.68 0.66 1.62 0.14 2.05 0.06
Critical period at 8 weeks postnatally 3.74 0.001 1.48 0.18 1.00 0.42
Critical period at 61 months postnatally 4.72 9.74 × 10−5 5.07 4.02 × 10−5 3.35 0.003
Accumulation of risk over time 3.89 7.77 × 10−4 5.83 5.77 × 10−6 4.19 3.68 × 10−4
Effect modification of critical period
in pregnancy by postnatal exposure
0.82 0.51 0.08 0.98 2.32 0.06
Critical period in pregnancy nested
within effect modification modela
0.40 0.67 4.8 0.009 1.50 0.22
Results of ANOVA test against a saturated model; a smaller F-statistic (and larger P-value) provides evidence of a better fit of data to the hypothesized model.
aResults of ANOVA test against effect modification model.
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Figure 5. Parental comparisons of associations between any versus no smoking in pregnancy on offspring methylation at CpG sites most associated with sustained maternal smoking in pregnancy at all three time points.
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Nonetheless, knowledge of smoking intensity in the first tri-
mester is important as a predictive marker of smoking later in
pregnancy and hence of epigenetic change in the offspring.
This has been confirmed in an analysis of 374 ARIES mothers–
child pairs for whom urinary cotinine was collected in the first
trimester of pregnancy. An EWAS of maternal cotinine levels and
cord blood methylation in this subsample was able to identify a
signal at AHRR (cg05575921), which surpassed the Bonferroni
threshold (P-value = 3.31 × 10−8; Supplementary Material, Fig. S8).
Whether pregnancy represents a critical period for determin-
ing offspring methylation patterns at later time points in child-
hood in response to maternal smoking was also investigated. A
longitudinal assessment of methylation marks associated with
maternal smoke exposure in pregnancy found that whereas
some CpG sites showed recovery of methylation to the level of
offspring not exposed (GFI1, KLF13 and ATP9A), other sites
showed persistently perturbed patterns (AHRR, MYO1G, CYP1A1
and CNTNAP2).
This prospective study design coupled with serial sampling at
multiple time points provides powerful evidence of the persist-
ence of DNA methylation changes induced in utero. In addition,
longitudinal modelling of the effects of exposure ‘windows’ pro-
vides evidence that prenatal exposure to smoking has persistent
effects on later offspring DNAmethylation, which outweighs the
postnatal influence of maternal smoking or own smoking in
adolescence at some CpG sites. Effect modification of prenatal
exposure at later time points was also evident, indicating that
postnatal exposure might have some further impact on the per-
sistence of the methylation marks in those exposed to smoking
in utero. However, there was no strong evidence that the effect
modification model was more consistent with the observed
data than the in utero critical period model at most sites. These
observations are consistent with and significantly extend previ-
ous analyses of long-term smoking-induced perturbations of
DNA methylation (15,23,24,26). One exception to this is the find-
ing that own smoking by the offspring at age 17 is strongly asso-
ciated with AHRR methylation at this time point which might
therefore be underlying the apparently persistent effect ofmater-
nal smoking in pregnancy at this gene region, as shown in
Figure 4. This is perhaps because this site is most sensitive to
smoking exposure and would therefore detect adolescent own
smoking most readily.
In addition, the use of paternal smoking as a negative control
demonstrates the biological effect of this in utero exposure at all
time points considered.Whilemethylation differences identified
between maternal and paternal smoking at later time points
might be attributed to the differential influences of these expo-
sures postnatally, the similar trends identified in cord blood
when no influence of the postnatal environment had been pre-
sent provide further support for the causal effect of maternal
smoking in pregnancy on offspring methylation. In addition,
the low levels of tobacco exposure from partner smoking in
non-smoking pregnant women in this cohort suggest that the
use of partner’s smoking as a negative control for investigating
intrauterine effects is valid (40). Mendelian randomization is an-
other technique that may be used to bolster causal inference
in this context (35,46,47). A SNP, rs1051730, located in the
CHRNA5-CHRNA3-CHRNB4 nicotinic acetylcholine receptor gene
cluster (chromosome 15q25), is robustly associatedwith smoking
heaviness (48) and has also been associated with a reduced abil-
ity of women to quit smoking in pregnancy (49). If an association
was observed between maternal rs1051730 and offspring DNA
methylation of mothers who smoked during pregnancy, this
would provide further evidence of an intrauterine effect.
However, we were underpowered to investigate this formally
within our sample of sustained smokers.
Strengths of our study include the application of the Illumina
Infinium® HM450 BeadChip technology to assess genome-wide
methylation profiles at multiple time points from birth until
late adolescence in a large, longitudinal cohort study. Thewealth
of phenotypic data in ALSPAC has aided the thorough assess-
ment of potential confounding factors, a detailed analysis of
the dose-dependence of methylation to smoke exposure in utero
and an investigation into the relative roles of intrauterine and
postnatal smoking using questionnaire data on smoking habits
taken from multiple time points in both parents and offspring.
Longitudinal modelling (50,51) and robust statistical methods
(34,39,52) have also been used to strengthen causal inference.
Limitations of the analysis include differential follow-up of
smokers compared with non-smokers, where only 14.3% of
mothers in the ARIES sample (selected based on blood sample
availability up to 17 years postnatally) smoked in pregnancy com-
paredwith 30.2% in thewider cohort. Technical limitations relate
to the HM450 BeadChip in that it covers only 1.7% of CpG sites
across the genome. A more comprehensive appraisal may elicit
additional relationships between the exposure in question and
DNA methylation, or indeed locus-specific paternal effects
which were not evident here (53–55). In addition, the use of ques-
tionnaires to obtain data on parental smoking may result in
under-reporting of smoking behaviour. However, to minimize
the influence of maternal under-reporting, we excluded from
the analyses individuals who had reported smoking before but
not during pregnancy. In addition, a strong correlation between
self-reported questionnaire data on smoking behaviour and plas-
ma cotinine levels has been found (18,40) and maternal cotinine
was found to be highly correlated with the sustained smoking
variable (r = 0.76) in the subsample of ARIES participants with
first trimester maternal cotinine data available (N = 323).
This analysis was limited to blood samples with mixed cell
composition. Although no differences were found in the analysis
with estimated cell-type correction, as has been shown previous-
ly (18,19), it is unclear how effective the method used to correct
for cell-type proportions is in these samples since the reference
data sets are available only for adult peripheral blood (56). In add-
ition, some of the DNA samples included in this analysis came
from buffy coats rather than whole blood and there is no refer-
ence cell-type correction available for buffy coat DNA. It should
also be emphasized that the associations identified may be spe-
cific to blood as an analysis of buccal epithelium and placenta did
not identify the same smoking-associated methylation differ-
ences in these tissues (23). This limitation of tissue specificity,
as well as the lack of expression data currently available on
these samples, limits the assessment of functional conse-
quences of these methylation changes.
Given evidence for causal associations between maternal
smoking in pregnancy andmethylation changes in the offspring,
it is important to consider whether these induced changes are
also associated with the adverse perinatal and offspring out-
comes associated with exposure to smoking in utero. Further
work is required which may link smoking-responsive DNA
methylation variation to health and development (57–59). In
addition, whether DNAmethylation is a truemediatingmechan-
ism of these associations or simply an exposure indicatormay be
explored by extending causal inference (35,47,60).
Transient environmental exposures during critical windows
of development are known to affect the establishment of epigen-
etic marks, which are evident at birth (57) and may persist until
later life (58,59). Findings from this study highlight the sensitivity
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of themethylome tomaternal smoking during fetal development
and the long-term impact of such an exposure. Results strength-
en causal inference in this area and the finding that sustained
smoking appears to be necessary to induce methylation changes
has profound implications for antenatal care and the long-term
effects on offspring health, directing potential intervention strat-
egies at cessation of smoking early in pregnancy, such as at the
first antenatal appointment.
These findings could also have very useful applications in epi-
demiological studies. Given the magnitude and persistence of
methylation change in relation to maternal exposure in utero, it
is important to consider the potential confounding effect of
maternal smoking in future EWAS studies attempting to identify
sites associated with own smoking. The persistence of some (but
not all) methylation marks at later time points presents the
opportunity to use methylation signatures as an archive of
historical exposure, particularly if methylation patterns can be
robustly modelled over time and previous exposure inferred.
A simplistic examplewould be to define prenatal smoking expos-
ure, using DNA methylation signatures in children of women
where no smoking history had been collected. In addition, the
contrast between stable and reversible sites may be useful in dis-
criminating between in utero exposure and later life exposure.
Materials and Methods
Study design
We examined offspring DNA methylation in relation to self-
reported maternal smoking during pregnancy in a subset of par-
ticipants from ALSPAC using methylation data from the Illumina
Infinium®HumanMethylation450 BeadChip assay (Illumina, Inc.,
CA, USA) (61).
Cohort and selection of participants
ALSPAC is a large, prospective cohort study based in the South
West of England. A total of 14 541 pregnant women resident in
Avon, UK, with expected dates of delivery 1 April 1991 to 31
December 1992 were recruited and detailed information has been
collected on these women and their offspring at regular intervals
(41,42). The study website contains details of all the data that are
available through a fully searchable data dictionary (http://www.
bris.ac.uk/alspac/researchers/data-access/data-dictionary/).
As part of the ARIES (http://www.ariesepigenomics.org.uk/)
project, the Infinium HM450 BeadChip has been used to generate
epigenetic data on 1018mother–offspring pairs in the ALSPAC co-
hort. The ARIES participants were selected based on availability
of DNA samples at two time points for the mother (antenatal
and at follow-up when the offspring was in adolescence) and at
three time points for the offspring [neonatal, childhood (age 7)
and adolescence (age 17)].
Written informed consent has been obtained for all ALSPAC
participants. Ethical approval for the study was obtained from
the ALSPAC Ethics and Law Committee and the Local Research
Ethics Committees.
Laboratory methods, quality control and pre-processing
Cord blood and peripheral blood samples (whole blood, buffy
coats or blood spots) were collected according to standard proce-
dures. The DNA methylation wet laboratory and pre-processing
analyses were performed at the University of Bristol as part of
the ARIES project. Following extraction, DNA was bisulphite-
converted using the Zymo EZ DNA MethylationTM kit (Zymo,
Irvine, CA, USA). Following conversion, genome-wide methyla-
tion status of over 485 000 CpG sites was measured using the
Infinium HM450 BeadChip according to the standard protocol.
The arrayswere scannedusing an Illumina iScan and initial qual-
ity review was assessed using GenomeStudio (version 2011.1).
The InfiniumHM450 BeadChip assay detects the proportion of
moleculesmethylated at each CpG site on the array. For the sam-
ples, the methylation level at each CpG site was calculated as a
beta value (β), which is the ratio of themethylated probe intensity
and the overall intensity and ranges from 0 (no cytosine methy-
lation) to 1 (complete cytosine methylation) (62,63). Methylation
data were pre-processed using in R (version 3.0.1), with back-
ground correction and subset quantile normalization performed
using the pipeline described by Touleimat and Tost (64).
Samples from all time points in ARIES were distributed across
slides using a semi-random approach (sampling criteria were in
place to ensure that all time points were represented on each
array) to minimize the possibility of confounding by batch
effects. In addition, during the data generation process a wide
range of batch variables were recorded in a purpose-built labora-
tory information management system (LIMS). The main batch
variable was found to be the bisulphite conversion (BCD) plate
number. Samples were converted in batches of 48 samples and
each batch identified by a plate number.
The LIMS also reported QC metrics from the standard control
probes on the 450K BeadChip for each sample. Samples failing
QC (average probe P-value of ≥0.01) were repeated and if unsuc-
cessful excluded from further analysis. As an additional QC
step genotype probes were compared with SNP-chip data from
the same individual to identify and remove any sample
mismatches. For individuals with no genome-wide SNP data,
samples were flagged if there was a sex-mismatch based on
X-chromosome methylation.
In addition to these QC steps, probes that contained <95% of
signals detectable above background signal (detection P-value
of <0.01; N = 7938) were excluded from analysis. After excluding
these probes, as well as control probes and probes on sex chro-
mosomes, a total of 466 432 CpG sites were included in the
main analysis for cord blood methylation. At age 7, 471 347 CpG
siteswere included and at age 17, 469 902 CpG siteswere included
in the main analysis, following the same exclusion criteria.
In utero exposure variables
Information on mothers’ smoking status during pregnancy was
obtained in questionnaires administered at 18 and 32 weeks of
gestation. Information was obtained about whether the mother
smoked in each trimester of pregnancy and the number of cigar-
ettes smoked on average per day. From these data, a dichotom-
ous variable for sustained maternal smoking during pregnancy
was derived. A mother was classified as a sustained smoker if
she smoked in all three trimesters, smoked in the first and
third trimester but not the second or smoked in the second and
third trimesters but not the first. The reference group consisted
of mothers who had reported not smoking in all three trimesters
or before pregnancy. We excluded all individuals who smoked in
one trimester only (i.e. not sustained) or who had missing infor-
mation of smoking for two or more trimesters. Of those with
missing information on one trimester, women were classified
as a sustained smoker if they said they smoked in the other
two trimesters.
For investigating the dose-dependent effects of maternal
smoking in pregnancy on DNAmethylation in cord blood, a vari-
able was derived for the duration of smoking in pregnancy (0, 1, 2
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or all three trimesters) aswell as the intensity of smoking in preg-
nancy (0, 1–4, 5–9, 10–14 and 15+ cigarettes/day).
Data on cotinine levels were available for a small subset of the
ARIES mothers (n = 374). Cotinine levels (ng/ml) were assessed
from a single urine sample taken during the first trimester of
pregnancy. For most mothers, the samples were collected as
part of routine clinical care but some samples were obtained
specifically for ALSPAC. Urine samples were stored at −20°C and
allowed to thaw at room temperature before use. Cotinine
was measured using the Cozart Cotinine Enzyme Immunoassay
(Concateno UK, Abingdon) urine kit. Where required, samples
were diluted using cotinine-free serum (fetal calf serum). Absorb-
ance was measured spectrophotometrically at a wavelength
of 450 nm. Maternal cotinine levels were categorized into
four groups: <70, 70–900, 900–3000 and >3000 ng/ml, which
roughly correspond with self-reported non-smoking, 1–4 cigar-
ettes per day, 5–14 cigarettes per day and >14 cigarettes per day,
respectively (40).
Offspring methylation outcome
The main outcome measure in this analysis was DNA methyla-
tion level at each of theCpG sites in cord blood samples. However,
we also undertook an EWAS for maternal prenatal smoking in
samples of peripheral blood when the children were age 7 and
17 years and followed up sites that reached genome-wide signifi-
cance to investigate the persistence of methylation marks in the
offspring over time.
Confounders
Variables considered as potential confounders in this analysis
were maternal age, pre-pregnancy BMI, pre-pregnancy weight,
parity, educational attainment, social class, alcohol intake and
paternal smoking. Maternal age at delivery was derived from
date of birth, which was recorded at that time. At enrolment,
the mother was asked to record her height and pre-pregnancy
weight, from which BMI was calculated. Mother’s parity was
also recorded in a questionnaire completed during pregnancy.
Based on questionnaire responses, highest educational qualifica-
tion for the mother was collapsed into one of the five categories
from none/ Certificate of Secondary Education (CSE, the lower
level of two national school exams that were taken when these
womenwere in school at age 16) to university degree. In addition,
the highest parental occupationwas used to allocate the children
to family social class groups using the 1991 British Office of Popu-
lation Censuses and Surveys classification. Self-reported alcohol
use was obtained in the questionnaire administered at 18 weeks
of gestation and individuals were categorized based on whether
they were non-drinkers, drank before 18 weeks of gestation or
were still drinking alcohol at 18 weeks of gestation. Information
on partners’ smoking during pregnancy was obtained from self-
reports at 18 weeks of gestation. Where self-reported data on
partner smoking were not available (16.3% of partners), maternal
reports were used. The bisulphite conversion batch for each sam-
ple was also included in the analysis to adjust for batch effects.
Statistical analysis
Using offspring DNA samples taken from cord blood (at birth), we
investigated methylation levels at 466 488 CpG sites across the
genome. Methylation β values at each CpG site were transformed
to obtain M-values [log2(β/(1− β)] for statistical analysis (62).
Multivariable linear regression was used to perform associ-
ation tests between maternal cigarette smoking and M-values
at each CpG site as the outcome. The main exposure measure
in our analysis was sustained smoking in pregnancy versus no
smoking and themain outcomewas cord bloodDNAmethylation
level. Analyseswere runwith andwithout adjustment for a num-
ber of potential confounders found to be associated with smok-
ing status in pregnancy (Table 2). DNA methylation sites were
annotated based on data provided by Illumina (63).
We first identified ‘EWAS-significant’ hits using a Bonferroni
correction, where associations below a threshold of 1.07 × 10−7
were considered a likely true positive worthy of further examin-
ation. However, this Bonferroni correction assumes independent
tests and so, as correlation of DNA methylation within gene
regions means that CpG sites may not be truly independent, a
less conservative FDR procedure based on the Benjamini–
Hochberg method was also used to account for multiple testing
(65). For this, CpG sites with FDR less than a 0.05 threshold were
labelled as EWAS-significant.
It has been demonstrated that differences in methylation can
arise as a result of variability of cell composition in whole blood
(56). As smoking is known to influence cell composition (66), in
order to ensure the results are not influenced by variation in
cell-type fraction between samples, we estimated the fraction
of CD8T-, CD4T-, NK- and B-cells, monocytes and granulocytes
in the samples using the estimateCellCounts function in the minfi
Bioconductor package implemented in R (67). We investigated
differences in estimated cell count by smoking status and ana-
lyses were repeated adjusting for cell composition by including
each blood cell fraction as a covariate in the multivariate linear
regression.
Given the previous evidence for sex-specificDNAmethylation
differences in relation to prenatal smoke exposure (68), we under-
took EWAS stratified by sex of the offspring and investigated
whether there were any sex-specific CpG sites found to be asso-
ciated with maternal smoke exposure.
We next used a web-based plotting tool, coMET (44), to inves-
tigate the genomic regions of interest from our main EWAS
analysis. This tool permits the visualization of methylation cor-
relation between CpG sites, which was limited to a maximum
of 75 CpG sites around to the top site of interest and within the
gene region identified. In addition, the plots were annotated
with functional genomic features based on the ENCODE project
(geneENSEMBL, CGI, ChromHMM, DNAse, RegENSEMBL and
SNPs).
Further analyses were performed to investigate whether the
level of methylation differed depending on the duration and in-
tensity of smoking to which the offspring were exposed in utero.
For this, the untransformed methylation β values for the top
CpG sites in each gene region reaching genome-wide significance
were plotted against a variable for the duration of smoking in
pregnancy as well as the intensity of smoking in pregnancy.
We also investigated whether the methylation alterations
associated with prenatal exposure to maternal smoking per-
sisted when the offspring were age 7 and 17 years. Longitudinal
methylation data were extracted from each of probe which
exceeded the Bonferroni threshold in cord blood. A multilevel
model (50,51) including a random intercept and a linear regres-
sion spline term to allow for flexibility was fitted to each of
these CpG sites sequentially:
methij ¼ β0 þ u0i þ β1 sustainedi þ β2 ageij þ β3 ðageij  7Þþ
þ β4 sustainedi ageij þ β5 sustainedi ðageij  7Þ þ
þ confounders þ εij
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εij
e
Nð0; σ2εÞ
u0i e Nð0; σ2uÞ
where i = 1, . . . (770) indexes the offspring in the analyses, j = 1, 2,
3 indexes themeasurement occasion and a+ = a if a > 0 or 0 other-
wise. β1 gives the average difference between smoker and non-
smoker offspring; β2 gives the average change in methylation
from birth to adolescence; β3 tells us whether there is any change
in this trend (i.e. β2) from childhood to adolescence; β4 tells us
whether there is a difference in methylation change between
smoker and non-smoker offspring and β5 tells us whether off-
spring of smokers and non-smokers have a different change to
the trend (i.e. β2) of methylation change from birth to childhood.
From thesewe can calculate the change inmethylation from 0 to
7 for children of non-smokers (β2) and smokers (β2+ β4), and the
change from7 to 17 for children of non-smokers (β2 + β3) and smo-
kers (β2 + β3 + β4 + β5). For each CpG site, we used a multilevel
model, adjusting for batch and the first 20 independent surrogate
variable components (which account for heterogeneity between
the cord blood and peripheral blood samples).
Strategies were then implemented to estimate the potential
role of non-intrauterine mechanisms in the observed associa-
tions at later time points. We first considered the potential role
of postnatal parental smoking in explaining the persistence of
methylation differences at age 7 and both parental and own
smoking at age 17 in the offspring of mothers who smoked com-
pared with the offspring of mothers who did not smoke in preg-
nancy. Additional information about mothers’ smoking status
postnatally was obtained in several questionnaires administered
after birth, including 8 weeks postpartum and 61 months post-
partum. In addition, information about own smoking status
was obtained in questionnaires completed by the offspring
when they were age 17.
For offspringmethylation at age 7, wewished to disentangle a
potential causal effect of maternal smoke exposure in utero (i.e. a
‘critical period’ hypothesis) from other lifecourse effects, includ-
ing the existence of postnatal critical periods of maternal smoke
exposure, an accumulation of risk with exposure over time or
effect modification of in utero exposure by postnatal exposure
(52). We implemented a structured approach tomodel the effects
of the binary maternal smoking exposure at three time points
(in pregnancy and postnatally at 8 weeks and 61 months) on off-
spring methylation. This involved first fitting a saturated model
with one coefficient for each combination of exposures at the
three time points (maternal smoking in pregnancy × 8 weeks
postnatally × 61 months postnatally) using the lm function in R
(version 3.0.1). We then specified a series of nestedmodels corre-
sponding to each lifecourse hypothesis to be tested against the
saturated model using an ANOVA test, with a smaller F-statistic
and a larger P-value indicating a better fit of the data to that
model. Nested models considered were an in utero critical period
(maternal smoking in pregnancy), later life critical periods
(maternal smoking 8 weeks and maternal smoking 61 months
postnatally), accumulation of risk across the three time points
(maternal smoking in pregnancy + 8 weeks postnatally + 61
months postnatally) and effect modification of in utero exposure
postnatally by smoking at the later time points [maternal smoking
in pregnancy + (smoking in pregnancy : 8 weeks postnatally) +
(maternal smoking in pregnancy : 61 months postnatally)].
For methylation at age 17, we also considered the potential in-
fluence of own smoking by the offspring in explaining persistence
in methylation signatures associated with intrauterine exposure
by running the samemultivariable linear regressions this time be-
tween ownsmoking status andmethylation as the outcome. From
the questionnaires administered when the adolescents were age
17, adolescentswho reported that they smokedmore thanonecig-
arette per week were classified as smokers and those who said
they had never tried a cigarette at either time point were classified
as non-smokers and used as the reference category. For this ana-
lysis,we did a look-upof the tophits in thematernal smokingana-
lysis in relation to own smoking in order to contrast effect sizes for
personal versusmaternal smoking associations withmethylation
at this time point. In addition, we repeated the main analysis at
this timepoint excluding those offspringwho reported ownsmok-
ing to investigate whether this had any influence on the results.
Finally, we compared associations of mothers’ and mothers’
partners’ smoking during pregnancy with offspring methylation
at the three time points (birth, age 7 and age 17), using partner
smoking during pregnancy as a negative control (34,36–40).
Information on partners’ smoking status during pregnancy was
obtained in a questionnaire administered at 18 weeks of gesta-
tion. In addition, mothers were asked about their partner’s cur-
rent smoking at 18 weeks of gestation. The correlation between
partner self-report and maternal report of partner smoking was
high (r = 0.95) and thereforematernal report was usedwhen part-
ners’ self-report information was missing. Mutually adjusted
models were built by including bothmaternal and partner smok-
ing to account for potential confounding by the smoking behav-
iour of the other parent.
EWAS were performed using the ‘CpG assoc’ package (version
2.11) implemented in R (version 3.0.1), multilevel modelling was
performed using Stata (version 13) and coMET was run via the
web interface (http://epigen.kcl.ac.uk/comet/upload.html). All
other analyses were implemented in R (version 3.0.1).
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Supplementary Material is available at HMG online.
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